Skip to main content

Table 1 Comparison of baseline characteristics of participants

From: Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS)

Subgroups

5-Year follow-up (n = 1888)

10-Year follow-up (n = 1450)

Non-CVD group (n = 1489)

CVD group (n = 399)

Non-CVD group (n = 974)

CVD group (n = 476)

Age, mean (SD)

52.08 (13.73)

61.50 (12.52) ‡

50.67 (12.73)

59.33 (11.78) ‡

Male, n (%)

632 (42.44)

183 (45.86)

420 (43.12)

209 (43.91)

BMI (kg/m2)

25.07 (4.76)

26.96 (4.64) ‡

24.95 (4.84)

26.89 (4.33) ‡

WC (cm) mean (SD)

82.2 (11.6)

88.8 (11.7) ‡

81.7 (11.9)

87.7 (10.9) ‡

Education (Univ.) n (%)

297 (19.97)

72 (17.80) ‡

216 (22.21)

80 (16.84) ‡

Cigarette smoking, n (%)

156 (10.48)

44 (11.03)

93 (9.55)

54 (11.34)

Low physical activity n (%)

627 (42.11)

174 (43.61)

396 (40.66)

213 (44.75)

FBS (mg/dl)

95.96 (27.81)

91 [83, 101]

104.55 (39.3) ‡

95 [85, 108]

94.22 (25.50)

90 [82, 100]

101.49 (31.25) ‡

94 [86, 106]

TC (mg/dl)

189.86 (41.81)

199.15 (41.7) ‡

187.26 (41.51)

201.96 (40.07) ‡

TG (mg/dl)

136.82 (89.04)

114 [81, 165]

156.4 (84.3) ‡

135 [99, 186]

131.80 (82.31)

114 [81, 165]

163.05 (98.58) ‡

137.5 [99,197.5]

HDL-C (mg/dl)

38.96 (9.58)

37.94 (9.50)

38.84 (9.45)

38.20 (9.66)

LDL-C (mg/dl)

124.00 (35.06)

130.8 (34.4) ‡

122.42 (35.10)

132.40 (33.77) ‡

SBP (mm Hg)

107.81 (12.34)

115.7 (11.37) ‡

107.13 (12.61)

115.22 (12.14) ‡

DBP (mm Hg)

73.14 (7.17)

76.15 (6.17) ‡

72.81 (7.43)

75.77 (6.79) ‡

LAP

36.48 (35.08)

27.6 [13.0, 48,4]

51.09 (38.10) ‡

42.3 [24.2, 65.2]

34.39 (32.92)

26.2 [12.0, 46.4]

52.04 (41.41) ‡

41.5 [23.99, 66.4]

TyG

8.61 (0.62)

8.84 (0.60) ‡

8.57 (0.59)

8.84 (0.64) ‡

VAI

2.76 (2.91)

2.02 [1.29, 3.21]

3.21 (2.38) †

2.48 [1.60, 3.97]

2.61 (2.49)

1.95[1.16, 2.91]

3.39 (3.16) ‡

2.47 [1.55, 4.14]

  1. CVD, cardiovascular disease; FBS, fasting blood sugar; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; WC, waist circumference; LAP, lipid accumulation product; TyG, triglyceride glucose index; VAI, visceral adiposity index
  2. Data are presented as Mean (SD) or Median [P25-75] for continuous measures, and n (%) for categorical measures
  3. Significant levels of †P < 0.01 and ‡P < 0.001 using ANOVA test